• Natural Compounds as COVID-19 Antiviral Leads

  2026-09-11

  This 2022 molecular modeling study screened natural compounds against two SARS-CoV-2 vulnerabilities: the 3CL protease and the spike receptor-binding domain. Its docking and molecular dynamics results prioritize several vitamin-related molecules for further antiviral therapeutics research, while also illustrating why computational binding predictions require biochemical and cellular validation.

• Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain

  2026-09-11

  This study identifies a mechanistic connection between reduced Kir4.1 activity in trigeminal satellite glial cells, ROS–p38 MAPK signaling, and Panx3-associated orofacial mechanical allodynia. Its combination of CCI-ION modeling, viral gene manipulation, behavioral testing, and pathway rescue experiments provides a framework for studying glial control of trigeminal pain while highlighting the need to distinguish p38-dependent effects from parallel MAPK pathways.

• Liraglutide, AVP, and the Brain–Kidney Axis

  2026-09-10

  Greenwood and colleagues combine a human before-and-after study with rat pituitary proteomics, phosphoproteomics, an AVP secretion reporter, and kidney signaling analysis to show that liraglutide can reduce circulating arginine vasopressin. The work links GLP-1 receptor agonism to sex- and time-dependent synaptic phosphorylation and downstream aquaporin 2 regulation, providing a mechanistic framework for understanding diuresis and natriuresis.

• EdU Imaging Kits (Cy3) for Bladder Cancer Studies

  2026-09-10

  EdU Imaging Kits (Cy3) provide denaturation-free S-phase labeling for quantifying bladder cancer cell proliferation by microscopy or flow cytometry. The workflow is especially useful for testing anoikis-related biology, SCD-associated growth, drug response, and tumor microenvironment models while preserving morphology and antigen accessibility.

• GSK J4 HCl: JMJD3 Inhibition Workflows

  2026-09-09

  GSK J4 HCl enables cell-based studies of JMJD3-dependent chromatin control, inflammatory signaling, and cancer biology. This practical guide connects dose design, histone-mark assays, macrophage TNF-α workflows, and a cautious extension of decidual CXCL10 research.

• Chromatin Programs Cardiomyocyte Perinatal Transition

  2026-09-09

  The reference study integrates chromatin accessibility, long-range regulatory interactions, and gene expression to explain how cardiomyocytes transition from fetal to neonatal states. Its identification of dynamic regulatory elements and MEF2/AP1-centered control networks provides a framework for interpreting cardiomyocyte maturation and for improving induced pluripotent stem cell-derived cardiomyocyte models.

• Standardized Whole-Blood Immunometabolism Assay

  2026-09-08

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with pharmacological modulation of cellular metabolism. The workflow preserves the complexity of human blood while enabling quantitative cytokine analysis, providing a practical framework for studying how glycolysis and other metabolic pathways shape immune responses.

• Cyclo (-RGDfC) for Reliable Integrin Assays

  2026-09-08

  This scenario-driven guide explains how Cyclo (-RGDfC), SKU A8790, can strengthen αvβ3 integrin experiments involving cell adhesion, migration, viability, and cytotoxicity readouts. It connects formulation, assay controls, protocol design, and supplier-selection decisions to practical laboratory reproducibility.

• Chicken ANP32A and Avian Influenza Polymerase

  2026-09-07

  This preprint identifies three cooperating determinants in chicken ANP32A—a SUMO-interacting motif, SUMOylation at K68/K153, and a segment of the avian-specific insertion—that enable efficient support of avian influenza virus polymerase. Its gain-and-loss-of-function framework explains why mammalian ANP32A/B, which lack two of these features, provide weaker support and offers a mechanistic view of host restriction.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-09-07

  Use ratiometric JC-1 fluorescence to connect mitochondrial depolarization with apoptosis, drug response, and mitochondrial function analysis. This practical guide covers controls, workflow design, assay optimization, and how to interpret ΔΨm changes alongside the immunomodulatory findings reported for glabridin-gold(I) complex 6d.

• Cyclo (-RGDfC) for High-Throughput Integrin Assays

  2026-09-05

  Cyclo (-RGDfC) combines cyclic RGD recognition with a practical DMSO-based workflow for αvβ3 integrin studies. Paired with 96-well hydrogel printing and localized light activation, c(RGDfC) can support spatially resolved adhesion, migration, angiogenesis, and tumor-targeting experiments.

• HOBt in Peptide Coupling and Indazole SAR

  2026-09-04

  HOBt (1-Hydroxybenzotriazole) is more than a conventional peptide coupling additive: its activated-ester chemistry can shape stereochemical quality and downstream medicinal chemistry decisions. This article connects HOBt-enabled amide bond formation with the modular synthesis and assay interpretation of indazole glucagon receptor antagonists.

• BOP Reagent for Prodrug Synthesis Workflows

  2026-09-04

  BOP reagent provides a practical route to carboxyl group activation, phenyl ester preparation, and controlled amide bond formation in research-scale synthesis. This workflow guide connects peptide-coupling discipline with carrier-free triterpene prodrug research while clearly separating established study findings from proposed chemical adaptations.

• Clozapine N-oxide for DREADDs Workflows

  2026-09-03

  Clozapine N-oxide (CNO) enables reversible, cell-selective control of neuronal circuits through engineered muscarinic receptors. This workflow-oriented guide shows how to apply it to aversion studies, GPCR signaling research, assay validation, and troubleshooting without overinterpreting behavioral outcomes.

• Octyl-α-ketoglutarate: A Causal HIF-1α Assay Tool

  2026-09-03

  Octyl-α-ketoglutarate is a cell-permeable prolyl hydroxylase substrate for testing how α-ketoglutarate availability shapes HIF-1α regulation. This guide presents a causal assay framework that separates substrate rescue from broader metabolic and hypoxia effects.

7902 records 1/527 page Next 12345 下5页 Last page